OXB completes acquisition of remaining stake in US subsidiary Progression to full ownership aligns with global strategy and ...

Researchers from Purdue University and the U.S. Centers for Disease Control and Prevention have recently developed a novel influenza vaccine candidate that uses a bovine adenoviral (BAd) vector to ...

Kolkata: With the current Covid-19 situation showing no sign of slowing down, and with monsoon around the corner, health ...

OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to ...

OXB (LSE: OXB) ("the Company”), a global quality and innovation-led cell and gene therapy CDMO, today highlights the launch of its Innovation and Technology Excellence Board (ITEB). The ITEB brings ...

Owing to the high pre-existing immunity (PEI) to Ad5, the development of an adenoviral vector with lower PEI and higher immunogenicity has been explored. However, the majority of the developed novel ...

The coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus in 2019 posed a significant challenge to healthcare systems worldwide, and investigators constructed a vaccine ...

CanSino Biologics. has filed a patent for a method of preparing an adenovirus vector vaccine using a perfusion culture process. The method involves adjusting the perfusion rate based on cell density ...